MENU
Agenda
  • Combining protein proximity detection with chromogenic multiplex: Discovering the PD1/PDL1 interactions
    APR 28, 2021 9:00 AM PDT
    Combining protein proximity detection with chromogenic multiplex: Discovering the PD1/PDL1 interactions
    Thierry P.P. van den Bosch, PhD
    Postdoctoral Researcher
  • November 13, 2020 6:00 PM PST | November 14, 2020 10:00 AM SGT
    Q&A Session (In the RoundTable Room)
    Charalambos C. Solomides, MD, Sara Eglitis, MS, QIHC, Faruk Erdem Kombak, MD, Srabani Bhaumik, PhD, Nelson Alexander, PhD
    Charalambos C. Solomides, MD
    Professor of Pathology Anatomy and Cell Biology, Sidney Kimmel Medical College / Thomas Jefferson University Hospital
    Sara Eglitis, MS, QIHC
    Former Scientist at NovoVita Histopath Laboratory, Currently Laboratory Director at StageBio
    Faruk Erdem Kombak, MD
    Research associate, Memorial Sloan Kettering Cancer Center
    Srabani Bhaumik, PhD
    Staff Scientist
    Nelson Alexander, PhD
    Research Leader, Roche Sequencing Solutions
  • Representative sampling to address tumor heterogeneity
    November 13, 2020 5:00 PM PST | November 14, 2020 9:00 AM SGT
    Representative sampling to address tumor heterogeneity
    Nelson Alexander, PhD
    Research Leader, Roche Sequencing Solutions
  • Fluorescent multiplexing of 3D spheroid FFPE with Roche automated stainer and reagents: assay optimization, imaging and future implications
    November 13, 2020 4:00 PM PST | November 14, 2020 8:00 AM SGT
    Fluorescent multiplexing of 3D spheroid FFPE with Roche automated stainer and reagents: assay optimization, imaging and future implications
    Srabani Bhaumik, PhD
    Staff Scientist
  • Simultaneous 5-plex Immunohistochemistry - MSKCC/PPBC experience
    November 13, 2020 3:00 PM PST | November 14, 2020 7:00 AM SGT
    Simultaneous 5-plex Immunohistochemistry - MSKCC/PPBC experience
    Faruk Erdem Kombak, MD
    Research associate, Memorial Sloan Kettering Cancer Center
  • Application of Ventana AmpHQ Technology at NovoVita
    November 13, 2020 2:00 PM PST | November 14, 2020 6:00 AM SGT
    Application of Ventana AmpHQ Technology at NovoVita
    Sara Eglitis, MS, QIHC
    Former Scientist at NovoVita Histopath Laboratory, Currently Laboratory Director at StageBio
  • Chromogenic multiplex IHC; the future of immunohistochemistry for the practicing pathologist and for research
    November 13, 2020 1:00 PM PST | November 14, 2020 5:00 AM SGT
    Chromogenic multiplex IHC; the future of immunohistochemistry for the practicing pathologist and for research
    Charalambos C. Solomides, MD
    Professor of Pathology Anatomy and Cell Biology, Sidney Kimmel Medical College / Thomas Jefferson University Hospital
  • November 12, 2020 11:00 AM PST | 6:00 PM GMT
    Q&A Session (In the RoundTable Room)
    Charalambos C. Solomides, MD, Sara Eglitis, MS, QIHC, Faruk Erdem Kombak, MD, Srabani Bhaumik, PhD, Nelson Alexander, PhD
    Charalambos C. Solomides, MD
    Professor of Pathology Anatomy and Cell Biology, Sidney Kimmel Medical College / Thomas Jefferson University Hospital
    Sara Eglitis, MS, QIHC
    Former Scientist at NovoVita Histopath Laboratory, Currently Laboratory Director at StageBio
    Faruk Erdem Kombak, MD
    Research associate, Memorial Sloan Kettering Cancer Center
    Srabani Bhaumik, PhD
    Staff Scientist
    Nelson Alexander, PhD
    Research Leader, Roche Sequencing Solutions
  • Representative sampling to address tumor heterogeneity
    November 12, 2020 10:00 AM PST | 5:00 PM GMT
    Representative sampling to address tumor heterogeneity
    Nelson Alexander, PhD
    Research Leader, Roche Sequencing Solutions
  • Fluorescent multiplexing of 3D spheroid FFPE with Roche automated stainer and reagents: assay optimization, imaging and future implications
    November 12, 2020 9:00 AM PST | 4:00 PM GMT
    Fluorescent multiplexing of 3D spheroid FFPE with Roche automated stainer and reagents: assay optimization, imaging and future implications
    Srabani Bhaumik, PhD
    Staff Scientist
  • Simultaneous 5-plex Immunohistochemistry - MSKCC/PPBC experience
    November 12, 2020 8:00 AM PST | 3:00 PM GMT
    Simultaneous 5-plex Immunohistochemistry - MSKCC/PPBC experience
    Faruk Erdem Kombak, MD
    Research associate, Memorial Sloan Kettering Cancer Center
  • Application of Ventana AmpHQ Technology at NovoVita
    November 12, 2020 7:00 AM PST | 2:00 PM GMT
    Application of Ventana AmpHQ Technology at NovoVita
    Sara Eglitis, MS, QIHC
    Former Scientist at NovoVita Histopath Laboratory, Currently Laboratory Director at StageBio
  • Chromogenic multiplex IHC; the future of immunohistochemistry for the practicing pathologist and for research
    November 12, 2020 6:00 AM PST | 1:00 PM GMT
    Chromogenic multiplex IHC; the future of immunohistochemistry for the practicing pathologist and for research
    Charalambos C. Solomides, MD
    Professor of Pathology Anatomy and Cell Biology, Sidney Kimmel Medical College / Thomas Jefferson University Hospital
  • Fully Automated IHC Multiplexing: Techniques and Assay Development
    NOV 12, 2020
    Fully Automated IHC Multiplexing: Techniques and Assay Development
    Mark Hellewell, PhD
    DISCOVERY Reagent & Training Lead, Companion Diagnostics (CDx) & DISCOVERY, Roche Tissue Diagnostics
  • Principles of Effective Method Development in Pathobiology Research
    NOV 12, 2020
    Principles of Effective Method Development in Pathobiology Research
    Vivian Barry, MS
    Gilead Sciences, Foster City, CA Jan., 2011 - current Associate Scientist I (2011-2013), Biologics and Target Biology Associate Scientist II (2014-2015), Biomarker / Biology Core Support
  • The Importance of Tissue Chemistry in Immunity-Oncology
    NOV 12, 2020
    The Importance of Tissue Chemistry in Immunity-Oncology
    Thomas M. Grogan, MD
    Professor Emeritus of Pathology, University of Arizona; Founder and Chief Scientific Advisor Emeritus, Ventana Medical Systems, Inc., a division of Roche
November 2020 - November 2021

DISCOVERY Global User Symposium

Roche and Labroots are pleased to announce the first-ever global DISCOVERY user symposium. This year long event will run from November 2020 to November 2021 and will focus on advancements in tissue research. This event is a peer-to-peer meeting, allowing you to hear from fellow researchers about their work with the DISCOVERY product portfolio.

Register Now to access the following content on demand:

  • View presentations from fellow researchers on their latest research
  • Send questions to our speakers
  • Visit our virtual lab to explore our technology
  • Visit Roche exhibits to learn about our research solutions
  • Ask the Experts – Connect with our DISCOVERY experts for helpful tips on creating your protocols and to get answers to technical questions about the DISCOVERY portfolio.

 

DISCOVERY products are for research use only. Not for use in diagnostic procedures.


Speakers

Show Resources
You May Also Like
JUN 08, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUN 08, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
The global pandemic has not only changed our plans for how we live and work, but also accelerated the need for innovation to protect human health. Join us for an Innovation Summit to hear fi...
JUN 17, 2021 3:00 PM BST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUN 17, 2021 3:00 PM BST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Each step in a diagnostic test's journey-from raw material extraction to patient administration-can influence outcomes....
JUN 09, 2021 6:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUN 09, 2021 6:30 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Bioprocess technology implementation is hard. Get ahead by getting it right. How do you know if you’re making the right decisions about bioproduction technologies? There is no universa...
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
Speakers

  • Thierry P.P. van den Bosch, PhD
    Postdoctoral Researcher
    Biography

      Thierry P.P. van den Bosch is a postdoctoral researcher for 3 years at the Erasmus University Medical Center, Rotterdam. In 2014 he graduated from the University of applied science in Leiden specialized as pathology technician. In 2018 he finished his PhD at the Erasmus University Medical Center on the subject: Monocytes and Macrophages in Solid Organ Transplantation. After finishing his PhD, he joined the department of Pathology – PARTS (Pathology and Research Trial Service) where he optimizes and introduces new technologies within the field of pathology and support scientists on specific scientific questions, especially in the field of chromogenic and immunofluorescent multiplexing.

    • Nelson Alexander, PhD
      Research Leader, Roche Sequencing Solutions
      Biography

        Nelson Alexander received his Ph.D. in Cancer Biology from the University of Arizona, followed by a post-doctoral fellowship at Vanderbilt University. Looking to have a more direct impact on patient care, he joined Roche Tissue Diagnostics (RTD) in 2007 where he has held multiple roles in R&D, as well as Research & Early Development. During his time at RTD Nelson became very interested in the interface between tumor heterogeneity and sampling bias. Nelson currently lead a research team within Roche Sequencing Solutions that is pioneering a new sampling process that enables the evaluation and quantification of tumor diversity at the genomic, transcriptomic, and cellular levels from entire solid tumors.

      • Srabani Bhaumik, PhD
        Staff Scientist
        Biography

          Srabani Bhaumik is a Staff Scientist in the Strategic Applications and Innovation Lab at Roche Tissue Diagnostics. Her R&D experiences includes molecular imaging, molecular pathology, small animal imaging, MRI contrast media imaging, reporter gene imaging, regenerative medicine and in-vitro assay development in oncology. Her current work is focused on fluorescent multiplexing (mIF) assay development on Roche automated IHC/ISH instruments, image acquisition and image analysis on multiple platforms. She was the technical lead for the development and launch of the fluorescent RUO 5-Plex assay on Roche Discovery platform. She has successfully developed complex fluorescent multiplex assays on various oncology samples including 3D cell spheroids and cytology. Prior to Roche, she worked at General Electric Global Research, where she focused on the MultiOmyx platform to explore immune oncology biomarker.

        • Sara Eglitis, MS, QIHC
          Former Scientist at NovoVita Histopath Laboratory, Currently Laboratory Director at StageBio
          Biography

            Sara Eglitis is a former scientist at NovoVita Histopath Laboratory, a CRO in Boston, MA specializing in a wide ranging of histopathology services including immunohistochemistry and digital image analysis. She is now Laboratory Director at StageBio.

          • Charalambos C. Solomides, MD
            Professor of Pathology Anatomy and Cell Biology, Sidney Kimmel Medical College / Thomas Jefferson University Hospital
            Biography

              Charalambos Solomides began his career in medicine at the Rheinishe Friedrich-Wilhelms University of Bonn, Germany, where he attended Medical School. Following graduation in 1988 with a Degree in Medicine he successfully completed his medical doctorate thesis in 1991, and graduated from the same university with a Doctorate of Medicine (Dr. Med.). Following 2 years in clinical research at Albany Medical College in NY, USA (1991-1993), he enrolled in the Residency Pathology Program of Temple University Hospital (TUH) in Philadelphia (1993). He completed his Residency in Pathology in 1998 and a Fellowship in Cytopathology 1999 at Thomas Jefferson University. He joined the faculty at TUH, Department of Pathology in 1999 as Assistant and later as Associate Professor of Pathology and Director of Cytopathology (2004). In 2009 he joined the Department of Pathology at Thomas Jefferson University Hospital in Philadelphia where is currently The Warren R. Lang Professor of Pathology, Anatomy and Cell Biology and Director of Cytopathology and the Immunohistochemistry Lab. His special interest is in Cytopathology and Lung Pathology. Charalambos has published over 70 publications in peer reviewed journals and 2 book chapters.

            • Faruk Erdem Kombak, MD
              Research associate, Memorial Sloan Kettering Cancer Center
              Biography

                Faruk Erdem Kombak is a research associate in Memorial Sloan Kettering Cancer Center, New York. He has been working in Precision Pathology Biobanking Center of this institution since September 2019. He was born in Turkey, in 1986 and completed his medical degree in Istanbul University, Turkey, in 2010. He finished his anatomical pathology residency in Marmara University, Turkey, in 2016. He worked as attending pathologist in Turkey for 3 years. In his current position; he performs histological and immunohistochemical assessment for clinical trials/scientific projects as well as multiplex immunohistochemistry and tissue microarray construction.

              • Vivian Barry, MS
                Gilead Sciences, Foster City, CA Jan., 2011 - current Associate Scientist I (2011-2013), Biologics and Target Biology Associate Scientist II (2014-2015), Biomarker / Biology Core Support
                Biography

                  Vivian Barry is a Senior Scientist in the Pathobiology group at Gilead Sciences.  She began her career in molecular biology and immunology research areas at DNAX and Genentech.  She eventually ventured into histopathology research and became the manager of the immunohistochemistry team at Arresto Biosciences in 2008.  Vivian joined Gilead in 2011, with the acquisition of Arresto, and has been managing the IHC/Pathology group at Gilead since that time.  Over the years, she has focused on building the histopathology lab and has introduced various machinery and techniques to enhance the delivery of high quality IHC and CISH data.  Her team focuses on target validation in both human tissues and animal models, assists in determining mechanism of action of therapeutics and small molecules, and is involved in IND-enabling studies.  She collaborates with investigators across Gilead's departments; these projects include virology, immunology, oncology, and fibrotic diseases.  Vivian received her Bachelor of Science and Master of Science degrees at the University of San Francisco, and has recently received her MBA from the Golden Gate University, San Francisco.

                • Thomas M. Grogan, MD
                  Professor Emeritus of Pathology, University of Arizona; Founder and Chief Scientific Advisor Emeritus, Ventana Medical Systems, Inc., a division of Roche
                  Biography
                    Dr. Thomas Grogan, MD, is professor emeritus at the University of Arizona College of Medicine. He is the founder and chief scientific advisor emeritus at Ventana Medical Systems, Inc., a division of Roche, a leading international healthcare leader based in Basel, Switzerland. Dr. Grogan grew up in unusual circumstances, as the son of a CIA officer father and a steel-willed mother, whose three sons experienced childhoods filled with peril in several foreign countries. He graduated from the University of Virginia, Phi Beta Kappa, with a degree in biology, and earned his medical degree with honors from the George Washington University School of Medicine. During his time in medical school, Dr. Grogan studied tropical medicine in Cebu, the Philippines. He did his internship and residency in the U.S. Army at Letterman Hospital in San Francisco and at Walter Reed Army Medical Center in Washington, D.C. He was a post-graduate fellow in hematopathology at Stanford University. A founding member of the International Lymphoma Study Group, Dr. Grogan has authored more than two hundred and fifty scientific papers and holds eighteen patents. His clinical practice contributions have been recognized in the Best Doctors in America, published by Woodward/White, Inc.) continuously from 1991 until his retirement in 2017. Chief among his innovations is the automation of cancer pathology testing technology that enables physicians to accurately identify the genetic characteristics of their patients' disease and manage their personalized treatment. Dr. Grogan has also been recognized for his medical and business accomplishments with many prestigious awards, including American Cancer Society Gift of Life Award (2003), Ernst and Young Entrepreneur of the Year Award (2002), Tom Brown Excellence in Entrepreneurship Award (2002), University of Arizona Outstanding Technology Innovation Award (2004). Dr. Grogan is a husband, father and grandfather, and he lives in Tucson, Arizona, with his wife of fifty-two years, Cande, who was a successful restaurateur.
                  • Mark Hellewell, PhD
                    DISCOVERY Reagent & Training Lead, Companion Diagnostics (CDx) & DISCOVERY, Roche Tissue Diagnostics
                    Biography

                      Mr. Hellewell has been with Roche Tissue Diagnostics (RTD) for 8 years where he has held several positions within the company. He began his career with RTD UK where he held sales and applications positions. In 2016 he relocated to Tucson, AZ to take up a global role with customer support for RTD. In 2017 he joined the DISCOVERY International Business team as Global Reagent and Training Lead, where he manages their reagent portfolio and global DISCOVERY training activities for customers and RTD personnel.

                    C.E. Credits

                    The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                    Help

                    General Labroots Questions

                    email support@labroots.com  

                    Virtual Events and Webinars

                    Supported Configurations

                    • Operating System Internet Explorer Firefox Chrome Safari
                      Vista IE8+ FF10+ Chrome15+
                      Windows 7 IE8+ FF10+ Chrome15+
                      Windows 8 IE10 FF10+ Chrome15+
                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                    • Cookie settings: session cookies enabled
                    • Browser configuration must have JavaScript enabled
                    • Adobe Flash player 10.2 or later

                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                    Internet Connection

                    • A minimum of 100Kbps is recommended for audio-only events
                    • A minimum of 300Kbps is recommended for speaker on-video events

                    Computer Equipment

                    • Screen Resolution: Minimum 1024x768
                    • Video Card: 65,000 colors minimum
                    • Sound card and speakers (or headphones) for hearing webcast in full format
                    • Audio Card: 16-bit minimum
                    • RAM: 512MB of free RAM

                    Firewall Protocol

                    • HTTP on port 80 or HTTPS on port 443
                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                    Work-At-Home Attendees

                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                    For A Seamless Experience

                    When using a mobile device, FREE Mobile Apps are available:

                    - For viewing Webinars:

                    - For viewing Virtual Events

                    Attendee Guide

                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                    Virtual Event and Webinar Support:

                    Continuing Education (CME/CE) Support

                    Loading Comments...
                    Show Resources
                    Attendees
                    • See more